Couldn't agree more. You can't really speak about sonics in absolutist terms. Even so-called audiophiles can't agree on ideal sonics - is it a hyperclean recording with zero distortion and incredible dynamic range on CD, or is it the sound of tubes and tape on vinyl?
Their therapeutic area focus was far too broad. Going after "dozens of diseases" in parallel was a recipe for disaster. It takes a very specific understanding of your disease to translate genetic insight into a mechanistic, testable hypothesis.
The real value they tried to build was in pharma, which is much more lucrative than either of those. Their data is somewhat interesting but limited by the lack of rich phenotypic/clincial information paired with the genetics.